| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 53,119 | 52,501 | 48,816 | 48,322 | | Cost of Revenue | 23,635 | 22,030 | 20,465 | 20,416 | | | Gross Profit | 29,484 | 30,471 | 28,351 | 27,906 | | | Operating Expenses | | Research Development | 9,639 | 9,425 | 8,180 | 7,497 | | Selling General and Administrative | 18,201 | 17,204 | 15,010 | 16,510 | | Non Recurring |
-
|
-
|
-
| 527 | | Others | (727) | 727 |
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,371 | 3,115 | 5,161 | 3,372 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 451 | 558 | 1,049 | 283 | | Earnings Before Interest And Taxes | 2,822 | 3,673 | 6,210 | 3,655 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 2,822 | 3,673 | 6,210 | 3,655 | | Income Tax Expense | 1,013 | 1,446 | 2,132 | 947 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,809 | 2,227 | 4,078 | 2,708 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,809 | 2,227 | 4,078 | 2,708 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,809 | $2,227 | $4,078 | $2,708 |
|
1.52% Nasdaq 0.00%
Income Statement
